Sanguine Novaseeds Profile
Key Indicators
- Authorised Capital ₹ 10.20 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.85 Cr
as on 11-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 166.00%
(FY 2022)
- Profit -4949.13%
(FY 2022)
- Ebitda 273.39%
(FY 2022)
- Net Worth -74.71%
(FY 2022)
- Total Assets 34.01%
(FY 2022)
About Sanguine Novaseeds
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.20 Cr and a paid-up capital of Rs 1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandra Shroff, Arun Ashar, Shilpa Sagar, and One other member serve as directors at the Company.
- CIN/LLPIN
U01112MH2015PTC260765
- Company No.
260765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanguine Novaseeds?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpa Sagar  | Additional Director | 30-Oct-2024 | Current |
| Sandra Shroff | Additional Director | 30-Oct-2024 | Current |
Arun Ashar  | Director | 08-Jan-2015 | Current |
| Rajnikant Shroff | Director | 08-Jan-2015 | Current |
Financial Performance of Sanguine Novaseeds.
Sanguine Novaseeds Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166% increase. The company also saw a substantial fall in profitability, with a 4949.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Novaseeds?
In 2022, Sanguine Novaseeds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Beil Infrastructure LimitedActive 27 years 5 monthsSandra Shroff, Arun Ashar and 1 more are mutual person
Uniphos Envirotronic Private LimitedActive 17 years 2 monthsSandra Shroff and Rajnikant Shroff are mutual person
Agri Net Solutions LimitedActive 24 years 8 monthsArun Ashar and Rajnikant Shroff are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguine Novaseeds?
Unlock and access historical data on people associated with Sanguine Novaseeds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Novaseeds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Novaseeds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
